Crude oil futures continued their upward trajectory during mid-morning Asian trade Dec. 11 as vaccine momentum intensified following an endorsement of the Pfizer-BioNTech vaccine by the US Food and Drug Administration advisory committee, and crude demand from India and China also supporting sentiment. At 10:58 am Singapore time (0258 GMT), the ICE Brent February contract was up 15 cents/b (0.3%) from the Dec. 10 settle to $50.41/b, while the January NYMEX light sweet crude contract was up 22 cents/b (0.47%) at $47/b. Both markers had closed at nine-month highs on Dec. 10, with the ICE Brent February contract rising 2.84% to settle at $50.25/b and the January NYMEX light sweet crude contract rising 2.77% to settle at $46.78. The risk-on sentiment in the market intensified after a committee of experts on the Vaccines […]